F 0658
Ensure services provided by the nursing facility meet professional standards of quality.
Level of Harm - Minimal harm
or potential for actual harm
Based on review of Pennsylvania's Nursing Practice Act, job descriptions, and clinical records, as well as
staff interviews, it was determined that the facility failed to correctly transcribe physician's orders for one of
five residents reviewed (Resident 2).
Residents Affected - Few
Findings include:
The Pennsylvania Code, Title 49, Professional and Vocational Standards, State Board of Nursing, 21.11
(a)(1)(2)(4) indicated that the registered nurse was to collect complete and ongoing data to determine
nursing care needs, analyze the health status of individuals and compare the data with the norm when
determining nursing care needs, and carry out nursing care actions that promote, maintain and restore the
well-being of individuals.
A job description for registered nurses, undated, indicated that the registered nurse was to ensure that the
highest degree of quality care was maintained at all times and was to provide direct nursing care as
needed.
An admission Minimum Data Set (MDS) assessment (a mandated assessment of a resident's abilities and
care needs) for Resident 2, dated April 3, 2024, indicated that the resident was cognitively impaired,
received a diuretic (water pill), and had diagnoses that included heart failure.
A nursing note, dated May 22, 2024, revealed laboratory results were reviewed with the Certified
Registered Nurse Practitioner (CRNP - a registered nurse who has advanced education and clinical training
in a health care specialty area), and new orders were received for 40 milligrams (mg) of Torsemide (water
pill) twice a day for two days and 20 milliequivalents of potassium chloride (supplement) daily for three days
and obtain a basic metabolic panel (BMP-blood test that checks the levels of different substances in your
blood) on May 24, 2024.
A laboratory result, dated May 24, 2024, was reviewed by the physician, and new orders were received to
continue the 40 mg of Torsemide twice a day. A nursing note written by Registered Nurse 2, dated May 24,
2024, at 3:05 p.m. revealed that the laboratory results were reviewed with the physician, new orders were
received to continue 40 mg of Torsemide twice a day indefinitely, and that the orders were updated.
A CRNP note, dated May 29, 2024, at 8:21 a.m., revealed that Resident 2 was fluid overloaded with 4+
pitting edema (severe swelling) of the lower extremities and that she was currently receiving 40 mg of
Torsemide twice a day. The plan was to add 50 mg of Spironolactone daily to the already ordered 40 mg of
Torsemide twice a day.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
395514
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395514
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/07/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Maybrook Hills Rehabilitation and Healthcare Cente
301 Valley View Boulevard
Altoona, PA 16602
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0658
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Resident 2's Medication Administration Record (MAR) for May and June 2024 revealed that the resident did
not receive 40 mg of Torsemide twice day from May 25 through June 7, 2024.
Interview with the Director of Nursing on August 7, 2024, at 3:32 p.m. confirmed that the registered nurse
who reviewed the laboratory results with the physician did not transcribe the new order for Torsemide into
the medical record; therefore, the 40 mg of Torsemide twice a day was not administered according to the
order.
28 Pa. Code 211.12(d)(1)(3)(5) Nursing Services.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
395514
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395514
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/07/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Maybrook Hills Rehabilitation and Healthcare Cente
301 Valley View Boulevard
Altoona, PA 16602
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0695
Provide safe and appropriate respiratory care for a resident when needed.
Level of Harm - Minimal harm
or potential for actual harm
Based on review of policies and clinical records, as well as observations and staff interviews, it was
determined that the facility failed to ensure that oxygen was provided as ordered by the physician for one of
five residents reviewed (Resident 1).
Residents Affected - Few
Findings include:
The facility's policy regarding oxygen use, dated May 8, 2024, indicated that the facility was to provide
oxygen as ordered by the physician.
A quarterly Minimum Data Set (MDS) assessment (a federally-mandated assessment of a resident's
abilities and care needs) for Resident 1, dated July 4, 2024, revealed that the resident was cognitively intact
and received oxygen. A care plan for the resident, dated February 22, 2024, revealed that the resident
received oxygen therapy. Physician's orders, dated July 10, 2024, included an order for the resident to
receive oxygen at two liters per minute (lpm) every shift for hypoxia (low levels of oxygen in your body
tissues).
Observations of Resident 1 on August 7, 2024, at 3:11 p.m. and 3:15 p.m. revealed that the resident had
oxygen in use via a concentrator (electrical machine that concentrates the oxygen from the air) at a flow
rate of five (5) lpm via nasal cannula (tube that delivers oxygen through the nose).
Interview with Licensed Practical Nurse 1 at the time of the second observation confirmed that Resident 1's
oxygen flow rate was set at five lpm and should have been set at two lpm as ordered.
28 Pa. Code 211.12(d)(1)(5) Nursing Services.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
395514
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395514
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/07/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Maybrook Hills Rehabilitation and Healthcare Cente
301 Valley View Boulevard
Altoona, PA 16602
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Ensure that residents are free from significant medication errors.
Level of Harm - Minimal harm
or potential for actual harm
Based on review of clinical records and staff interviews, it was determined that the facility failed to provide
medication as ordered by the physician, resulting in a significant medication error for one of five residents
reviewed (Resident 2).
Residents Affected - Some
Findings include:
An admission Minimum Data Set (MDS) assessment (a mandated assessment of a resident's abilities and
care needs) for Resident 2, dated April 3, 2024, indicated that the resident was cognitively impaired,
received a diuretic (water pill), and had diagnoses that included heart failure.
A nursing note, dated May 22, 2024, revealed that laboratory results were reviewed with the Certified
Registered Nurse Practitioner (CRNP - a registered nurse who has advanced education and clinical training
in a health care specialty area), and new orders were received for 40 milligrams (mg) of Torsemide (water
pill) twice a day for two days and 20 milliequivalents of potassium chloride (supplement) daily for three days
and obtain a basic metabolic panel (BMP - blood test that checks the levels of different substances in your
blood) on May 24, 2024.
A laboratory result, dated May 24, 2024, was reviewed by the physician, and new orders were received to
continue the 40 mg of Torsemide twice a day. A nursing note written by Registered Nurse 2, dated May 24,
2024, at 3:05 p.m. revealed that the laboratory results were reviewed with the physician, new orders were
received to continue 40 mg of Torsemide twice a day indefinitely, and that the orders were updated.
A CRNP note, dated May 29, 2024, at 8:21 a.m., revealed that Resident 2 was fluid overloaded with 4+
pitting edema (severe swelling) of the lower extremities and that she was currently receiving 40 mg of
Torsemide twice a day. The plan was to add 50 mg of Spironolactone daily to the already ordered 40 mg of
Torsemide twice a day.
Resident 2's Medication Administration Record (MAR) for May and June 2024 revealed that the resident did
not receive 40 mg of Torsemide twice day from May 25 through June 7, 2024.
Interview with the Director of Nursing on August 7, 2024, at 3:32 p.m. confirmed that the registered nurse
who reviewed the laboratory results with the physician did not transcribe the order for the Torsemide into
the medical record; therefore, the 40 mg of Torsemide twice a day was not administered according to the
order.
28 Pa. Code 211.12(d)(1)(3)(5) Nursing Services.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
395514
If continuation sheet
Page 4 of 4